BELIFT LAB to appeal ruling in 2 billion won lawsuit against Min Hee-jin
BELIFT LAB, the agency for the group ILLIT, announced it will immediately appeal a first-instance court ruling that dismissed its 2 billion won damages lawsuit against former ADOR CEO Min Hee-jin.
BELIFT LAB announced on the 13th that it will appeal a Seoul Western District Court ruling that dismissed its 2 billion won damages lawsuit against former ADOR CEO Min Hee-jin. The court also dismissed a 5 billion won countersuit filed by Min, following her April 2024 claims that ILLIT imitated NewJeans.
BELIFT LAB, the agency for the group ILLIT, announced on the 13th that it will immediately appeal after losing the first instance of a damages lawsuit seeking 2 billion won against former ADOR CEO Min Hee-jin. BELIFT LAB stated, "It is very regrettable that a ruling was issued to the effect that there are victims but no perpetrator."
On this day, the 12th Civil Division of the Seoul Western District Court ruled against the plaintiffs in the damages lawsuits filed by BELIFT LAB and Source Music against former CEO Min, which were for 2 billion won and 500 million won, respectively. The 5 billion won countersuit filed by former CEO Min against BELIFT LAB was also dismissed.
BELIFT LAB pointed out, "If we prematurely grant an indulgence on the grounds of 'expression of opinion' or 'rhetorical expression,' second and third victims will continue to emerge." The agency also claimed that although investigative authorities requested the resumption of oral arguments by submitting a decision to transfer the case with an opinion to indict following Min's remarks, the request was not accepted, and newly secured evidence was not examined.
This lawsuit began in April 2024 when former CEO Min claimed during a press conference that ILLIT imitated the concept and choreography of NewJeans. BELIFT LAB, calling these claims groundless, filed a complaint against former CEO Min for obstruction of business and defamation and initiated the damages lawsuit; related criminal trials are also separately ongoing.
Covers K-pop for SPECIALTIMES GLOBAL, and also writes Culture and K-Variety stories.
Comments 0
Comments are currently disabled.